Browse studies, page 422
Page 422 of 1,298, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- A network meta-analysis: evaluating the efficacy and safety of concurrent proton pump inhibitors and clopidogrel therapy in post-PCI patients Frontiers in Cardiovascular Medicine, 2024
- Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units The Cochrane database of systematic reviews, 2018
- Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease The Cochrane database of systematic reviews, 2013
- High-dose vs low-dose proton pump inhibitors for upper gastrointestinal bleeding: a meta-analysis World journal of gastroenterology, 2010
- Meta-analysis: the effects of placebo treatment on gastro-oesophageal reflux disease Alimentary pharmacology & therapeutics, 2010
- Proton pump inhibitors for functional dyspepsia The Cochrane database of systematic reviews, 2017
- Pharmacological and surgical interventions for the treatment of gastro-oesophageal reflux in adults and children with asthma The Cochrane database of systematic reviews, 2021
- Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis Gut, 2014
- Deprescribing versus continuation of chronic proton pump inhibitor use in adults The Cochrane database of systematic reviews, 2017
- Proton pump inhibitor for non-erosive reflux disease: a meta-analysis World journal of gastroenterology, 2013
- N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication The Cochrane database of systematic reviews, 2019
- Is the era of intravenous proton pump inhibitors coming to an end in patients with bleeding peptic ulcers? Meta-analysis of the published literature British journal of clinical pharmacology, 2016
- Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1 Nature medicine, 2022
- Host Genetic Determinants Associated With Helicobacter pylori Eradication Treatment Failure: A Systematic Review and Meta-analysis Gastroenterology, 2021
- Effectiveness and Tolerability of Different Recommended Doses of PPIs and H2RAs in GERD: Network Meta-Analysis and GRADE system Scientific reports, 2017
- Proton Pump Inhibitors Do Not Reduce the Risk of Esophageal Adenocarcinoma in Patients with Barrett's Esophagus: A Systematic Review and Meta-Analysis PloS one, 2017
- Lifestyle interventions can reduce the risk of Barrett's esophagus: a systematic review and meta-analysis of 62 studies involving 250,157 participants Cancer medicine, 2021
- High-dose vs. Low-dose Proton Pump Inhibitors post-endoscopic hemostasis in patients with bleeding peptic ulcer. A meta-analysis and meta-regression analysis The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2018
- Proton pump inhibitor use and risk of dementia: Systematic review and meta-analysis Medicine, 2019
- Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants The Cochrane database of systematic reviews, 2019
- Does the use of proton pump inhibitors increase the risk of hypomagnesemia: An updated systematic review and meta-analysis Medicine, 2019
- Efficacy and Safety of Vonoprazan-Based versus Proton Pump Inhibitor-Based Triple Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Clinical Trials BioMed research international, 2019
- No evidence for the benefit of PPIs in the treatment of acute pancreatitis: a systematic review and meta-analysis Scientific reports, 2023
- Use of proton pump inhibitors and the risk of hepatocellular carcinoma: A systematic review and meta-analysis Journal of the Chinese Medical Association : JCMA, 2019
- Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies Drug design, development and therapy, 2017
- Assessing the Risk of Hospital-Acquired Clostridium Difficile Infection With Proton Pump Inhibitor Use: A Meta-Analysis Infection control and hospital epidemiology, 2016
- Proton pump inhibitors and hypomagnesemia: A meta-analysis of observational studies Medicine, 2019
- Do proton pump inhibitors prevent Barrett's esophagus progression to high-grade dysplasia and esophageal adenocarcinoma? An updated meta-analysis Journal of cancer research and clinical oncology, 2021
- Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis European journal of clinical pharmacology, 2020
- Systematic review with network meta-analysis: indirect comparison of the efficacy of vonoprazan and proton-pump inhibitors for maintenance treatment of gastroesophageal reflux disease Journal of gastroenterology, 2019
- A comparison of efficacy and safety of potassium-competitive acid blocker and proton pump inhibitor in gastric acid-related diseases: A systematic review and meta-analysis Journal of gastroenterology and hepatology, 2022
- Impact of proton pump inhibitors on the risk of small bowel or colorectal bleeding: A systematic review and meta-analysis United European gastroenterology journal, 2023
- Will Proton Pump Inhibitors Increase the Risk of Diabetes Mellitus? A Systemic Review and Meta-Analysis The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2022
- Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists Scientific reports, 2023
- Network Meta-Analysis of Comparing Different Dosages of Potassium-Competitive Acid Blocker With Proton-Pump Inhibitor in Acid-Related Disorders Clinical and translational gastroenterology, 2024
- Efficacy and Safety of Potassium-Competitive Acid Blockers vs Proton Pump Inhibitors for Peptic Ulcer Disease or Postprocedural Artificial Ulcers: A Systematic Review and Meta-analysis Clinical and translational gastroenterology, 2024
- Effectiveness of eradication therapy for Helicobacter pylori infection in Africa: a systematic review and meta-analysis BMC gastroenterology, 2023
- Efficacy and safety of Saccharomyces boulardii as an adjuvant therapy for the eradication of Helicobacter pylori: a meta-analysis Frontiers in cellular and infection microbiology, 2025
- Effect of proton pump inhibitors on the clinical outcomes of PD-1/PD-L1 inhibitor in solid cancer patients Medicine, 2022
- Proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug-induced ulcers and dyspepsia The Cochrane database of systematic reviews, 2025
- Proton pump inhibitors are not associated with an increased risk of Clostridioides difficile infection: a systematic review and meta-analysis of randomized controlled trials Gut microbes, 2025
- The Effect of Proton Pump Inhibitors on Bone Mineral Density at Specific Anatomical Sites: A Systematic Review and Meta-Analysis BioMed research international, 2025
- Association of Proton Pump Inhibitor Use With Gastric Cancer in Regions With High Prevalence of Gastric Cancer: Systematic Review and Meta-analysis Journal of neurogastroenterology and motility, 2025
- A Systematic Review and Meta-Analysis of Randomized Controlled Trials on the Benefits of Using Lactobacillus Supplements as an Adjunct Treatment for Helicobacter pylori Eradication MicrobiologyOpen, 2025
- Potassium-competitive Acid Blockers Versus Proton Pump Inhibitors for Erosive Esophagitis: A Systematic Review and Network Meta-analysis Journal of neurogastroenterology and motility, 2026
- The efficacy and safety of proton-pump inhibitors in treating patients with non-erosive reflux disease: a network meta-analysis Scientific reports, 2016
- Comparative effectiveness and acceptability of the FDA-licensed proton pump inhibitors for erosive esophagitis: A PRISMA-compliant network meta-analysis Medicine, 2017
- Research Paper Identification, Synthesis and Characterization of P otential Impurities of Dexlansoprazole 2013
- Formulation development and in-vitro evaluation of dexlansoprazole loaded double walled microspheres 2021
- Formulation and Evaluation of Dexlansoprazole-Loaded Solid Lipid Nanoparticles for Solubility Enhancement Zenodo (CERN European Organization for Nuclear Research), 2025
- Pharmacology of dexlansoprazole and its application in treating gastroesophageal reflux disease Zhongguo xin yao zazhi, 2012
- Determination of Optical Purity of Dexlansoprazole Sustained-release Capsules by HPLC Zhongguo yaofang, 2014
- The effects of increasing body mass index on heartburn severity, frequency and response to treatment with dexlansoprazole or lansoprazole Alimentary Pharmacology & Therapeutics, 2013
- Design, formulation, and evaluation of dexlansoprazole oral thin films World Journal of Pharmaceutical Research, 2026
- Formulation and evaluation of dexlansoprazole controlled release tablets International Journal of Pharmaceutical, Biological and Chemical Sciences, 2025
- Pharmacokinetics of Dexlansoprazole Capsules with a Biphase Release in Beagle Dogs Chinese Journal of Pharmaceuticals, 2011
- Dexlansoprazole MR in the Management of Gastroesophageal Reflux Disease Clinical Medicine Therapeutics, 2009
- Development and Validation of UV-Visible Spectrophotometric Method for Estimation of Dexlansoprazole Journal of Drug Delivery and Therapeutics, 2025
- Dexlansoprazole Delayed Release: Pharmacotherapy of Erosive Esophagitis and GERD Clinical Medicine Insights Therapeutics, 2011
- FDA approves brand-name change for dexlansoprazole 2010
- Formulations and Characterization of Liquid SMEDDS of Dexlansoprazole Frontiers in Health Informatics, 2025
- Pharmacokinetics and clinical efficacy of dexlansoprazole MR World Clinical Drugs, 2011
- Formulation and Evaluation of Dexlansoprazole Floating Tablets International Journal of Pharmacy and Life Sciences, 2020
- The Effect of Food on the Bioavailability of Dexlansoprazole From the Dexlansoprazole Orally Disintegrating Tablet Formulation The American Journal of Gastroenterology, 2014
- Synthesis technology of dexlansoprazole Xiandai yaowu yu linchuang, 2013
- Synthesis of Dexlansoprazole Chemistry & Bioengineering, 2014
- Novel Therapy Combining Regenerative Stimuli Immunomodulation to Preserve Beta Cell Function in New Onset Type 1 Diabetes ClinicalTrials.gov · TERMINATED, 2011
- A Phase 3, Multicenter, Randomized, Double-blind, AG-1749-controlled, Parallel-group, Comparison Study to Evaluate the Efficacy and Safety of TAK-438 (10 mg or 20 mg, Orally, Once Daily) for the Prevention of Recurrent Gastric or Duodenal Ulcers During Long-term Therapy of Non-steroidal Anti-inflammatory Drug (NSAID) ClinicalTrials.gov · COMPLETED, 2013
- A Phase 1, Single-Center, Open-Label, 2-Arm Parallel Group, Single-Dose Study to Evaluate the Pharmacokinetics of Dexlansoprazole 30 mg and 60 mg Delayed-Release Capsules in Healthy Chinese Subjects ClinicalTrials.gov · COMPLETED, 2018
- A Double-Blinded, Placebo-Controlled Trial to Investigate Dexlansoprazole for the Treatment of Laryngopharyngeal Reflux ClinicalTrials.gov · TERMINATED, 2013
- Peripheral Blood Dendritic Cells and Periodontitis ClinicalTrials.gov · COMPLETED, 2014
- Physiologic Determinants of PPI Disposition in Children ClinicalTrials.gov · COMPLETED, 2024
- A Pilot Study - Lansoprazole in Preterm Infants With Gastroesophageal Reflux ClinicalTrials.gov · COMPLETED, 2013
- A Phase 3, Randomized, Double Blind, Double-Dummy, Multicenter, Parallel Group Comparison Study to on Efficacy and Safety of Oral Once-Daily Administration of TAK-438 20 mg Comparing With AG-1749 in Patients With Gastric Ulcer ClinicalTrials.gov · COMPLETED, 2012
- A Randomized, Double-Blind, Phase 4 Study to Evaluate the Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency Ablation ClinicalTrials.gov · TERMINATED, 2016
- A Phase 3, Randomized, Double-blind, Active-controlled, Multicenter Study to Evaluate the Efficacy and Safety of a Triple Therapy With CJ-12420, Amoxicillin and Clarithromycin in H. Pylori Positive Patients ClinicalTrials.gov · COMPLETED, 2019
- A Study to Examine The Potential Effect Of Lansoprazole On The Pharmacokinetics Of Bosutinib When Administered Concomitantly To Healthy Subjects ClinicalTrials.gov · COMPLETED, 2009
- A Phase 3, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group Study Assessing the Safety and Efficacy of Lansoprazole Microgranules Oral Suspension in Infants With Symptomatic Gastroesophageal Reflux ClinicalTrials.gov · COMPLETED, 2007
- Intraluminal Therapy for Helicobacter Pylori Infection ClinicalTrials.gov · COMPLETED, 2018
- Cardiac Transfer of SARS-CoV-2 Spike Protein Circulation Techniques - Medicine Induced Hemodialysis on "Vaccinated" Immune Attacks ClinicalTrials.gov · COMPLETED, 2023
- Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux Disease ClinicalTrials.gov · COMPLETED, 2008
- Effects of Lansoprazole on Sitagliptin Glucose-lowering Ability in Healthy Males ClinicalTrials.gov · COMPLETED, 2013
- A Phase 1, Open-Label, Randomized, Crossover Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vonoprazan (20 mg) and Lansoprazole (30 mg) in Healthy Subjects ClinicalTrials.gov · COMPLETED, 2021
- Therapeutic Effect of Vonoprazan Versus Dexlansoprazole in Treatment of Gastroesophageal Reflux Disease in Egyptian Patients: A Prospective Comparative Study ClinicalTrials.gov · COMPLETED, 2024
- An Open-label, Randomized, 4-treatment, 3-period, Crossover Interaction Study, Evaluating the Effect of Esomeprazole 40 mg, Omeprazole 80 mg or Lansoprazole 60 mg on the Pharmacodynamics and the Pharmacokinetics of Clopidogrel in Healthy Volunteers ClinicalTrials.gov · COMPLETED, 2011
- A Phase 3, Randomized, Double Blind, Multicenter, Placebo Controlled Study to Evaluate the Efficacy and Safety of Febuxostat 40 mg XR, 80 mg XR, 40 mg IR and 80 mg IR in Subjects With Gout ClinicalTrials.gov · COMPLETED, 2015
- Is Long-Term Proton Pump Inhibitor Use a Cause of Leaky Gut Syndrome: A Cross-Sectional Case-Control Study ClinicalTrials.gov · COMPLETED, 2023
- Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?: A Randomized Controlled Trial ClinicalTrials.gov · COMPLETED, 2014
- A Randomized, Open-Label, Comparative, Two-Treatment, Crossover Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects on Days 1 and 5 of Intravenous Treatment ClinicalTrials.gov · COMPLETED, 2006
- Lansoprazole in Preterm Infants With Gastroesophageal Reflux ClinicalTrials.gov · COMPLETED, 2014
- Implementation of Pharmacogenomic Testing in Nemours Children's Health System ClinicalTrials.gov · COMPLETED, 2018
- Do Laryngeal Biopsy Findings Predict Treatment Response in Suspected Laryngopharyngeal Reflux ClinicalTrials.gov · COMPLETED, 2009
- A Phase 4, Open-Label Study in Patients From Asia With Gastroesophageal Reflux Disease Treated With Dexlansoprazole ClinicalTrials.gov · COMPLETED, 2016
- Elucidation of Acid-Induced Pulmonary Inflammation ClinicalTrials.gov · TERMINATED, 2009
- A Phase 1, Randomized, Open-Label, 2-Period, Crossover Design Study to Assess the Effects of Multiple Oral Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Steady-State Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Subjects ClinicalTrials.gov · COMPLETED, 2010
- Role of Empiric Anti-reflux Therapy in Pediatric Otitis Media With Effusion - a Pilot Study ClinicalTrials.gov · COMPLETED, 2014
- Randomized Open Labeled Clinical Trial: a Comparative Study of 10-day High Dose PPI-based Triple Therapy vs. 10-day Sequential Therapy for Helicobacter Pylori Eradication in Functional Dyspepsia Patients ClinicalTrials.gov · COMPLETED, 2014
- A Phase 3 Study to Evaluate the Efficacy and Safety of Dexlansoprazole (60 mg QD) and an Active Comparator, Lansoprazole (30 mg QD) on Healing of Erosive Esophagitis, and Maintenance of Healing in Subjects With Healed Erosive Esophagitis With Dexlansoprazole (30 mg QD) and Placebo ClinicalTrials.gov · TERMINATED, 2017
- Role of Mosapride in Patients With Gastroesophageal Reflux Disease ClinicalTrials.gov · COMPLETED, 2009
- A Randomized Double-blind, Double Dummy, Active Comparator-controlled Dose-finding Study in Patients With Erosive Esophagitis Due to Gastro-esophageal Reflux Disease (GERD) Los Angeles Grade C or D, and Patients With at Least Partial Symptom Response But Endoscopically Still Unhealed After 8 Weeks History of Standard Treatment Healing Course With Proton-pump Inhibitor (PPI), to Investigate Safety, Tolerability, and Healing Rates After 4 Weeks Treatment of X842 or Lansoprazole, and Symptom Pattern During Subsequent 4 Weeks Treatment With Lansoprazole ClinicalTrials.gov · COMPLETED, 2022
